Filing Details

Accession Number:
0001179110-17-005277
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-03-30 17:48:07
Reporting Period:
2017-03-28
Filing Date:
2017-03-30
Accepted Time:
2017-03-30 17:48:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1358762 Reata Pharmaceuticals Inc RETA Pharmaceutical Preparations (2834) 113651945
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1551152 Abbvie Inc. 1 North Waukegan Road
North Chicago IL 60064-6400
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Disposition 2017-03-28 450,000 $22.50 1,190,473 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct